Latest News about TVTX
Recent news which mentions TVTX
Earnings Scheduled For November 7, 2023
November 07, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
September 22, 2023
From Benzinga
Micron Technology To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Friday
September 22, 2023
From Benzinga
Back To Back Trial Failures: Analyst Weighs In On Travere Therapeutics' Prospects, Challenges
September 21, 2023
Tickers
TVTX
From Benzinga
Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit
September 21, 2023
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 21, 2023
From Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
September 21, 2023
From Benzinga
Why Shares of Travere Therapeutics Are Slumping Thursday
September 21, 2023
From Motley Fool
Stocks That Hit 52-Week Lows On Thursday
September 21, 2023
From Benzinga
Gold Down Over 1%; FedEx Shares Rise On Earnings Beat
September 21, 2023
From Benzinga
Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected
September 21, 2023
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 21, 2023
From Benzinga
Broadcom, KB Home And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
September 21, 2023
From Benzinga
Evercore ISI Group Maintains Outperform Rating for Travere Therapeutics: Here's What You Need To Know
September 19, 2023
Tickers
TVTX
From Benzinga
EXCLUSIVE: Kidney Care Revolution? How Swedish Biopharma Calliditas Aims To Tackle A Rare Disease With 'Unique, But Pretty Simple' Drug
September 08, 2023
From Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
From Benzinga
3 Small-Cap Stocks That Could Be Big-Time Winners
July 22, 2023
From Motley Fool
From Benzinga
Travere Therapeutics Offloads Bile Acid Product Portfolio: Says Divestment Strengthens Financial Foundation
July 17, 2023
From Benzinga
From Benzinga
Novartis deal for Chinook makes kidney-treatment competitors more attractive, analysts say
June 12, 2023
From MarketWatch
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
More ways to get to us
Facebook
Twitter
YouTubeContact the Lethbridge Herald
504 - 7th Street South
Lethbridge, AB T1J 3Z7
[P] (403) 328-4411
[F] (403)328-4536
Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433
© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.